We welcome translational projects and startups that are less than 5 years old and have raised less than 5 million. Our competition is open to all products and technologies that help fight AMR, including therapeutics, diagnostics, vaccines, and digital health tools. The #AMRconference is a platform for various stakeholders to discuss strategies and challenges in bringing new antimicrobial treatments and diagnostics to the market. The conference covers scientific, regulatory, financial, and policy topics, providing the latest trends in AMR product development. It also offers a partnering platform for interactions, covering the entire innovation value chain.